DEUTSCHE BANK AG\ - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 64 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q1 2021$155,000
+93.8%
56,215
+71.1%
0.00%
Q4 2020$80,000
+90.5%
32,851
+64.0%
0.00%
Q3 2020$42,000
-39.1%
20,036
+9.4%
0.00%
Q2 2020$69,000
+228.6%
18,313
+62.6%
0.00%
Q1 2020$21,000
-69.6%
11,263
-66.4%
0.00%
Q4 2019$69,000
+228.6%
33,513
+268.2%
0.00%
Q3 2019$21,000
-88.5%
9,102
-84.5%
0.00%
Q2 2019$182,000
+1922.2%
58,656
+2917.3%
0.00%
Q1 2019$9,000
-98.3%
1,944
-98.3%
0.00%
Q4 2018$518,000
-56.0%
115,700
-52.3%
0.00%
Q3 2018$1,176,000
-21.6%
242,510
-3.0%
0.00%
Q2 2018$1,500,000
+164.1%
250,074
+288.3%
0.00%
Q1 2018$568,000
+40.9%
64,409
+15.6%
0.00%
Q4 2017$403,000
+203.0%
55,711
+185.0%
0.00%
Q3 2017$133,000
-25.3%
19,551
-22.3%
0.00%
Q2 2017$178,000
+5833.3%
25,157
+1472.3%
0.00%
Q4 2016$3,0001,6000.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q2 2018
NameSharesValueWeighting ↓
CAXTON CORP 6,612,065$15,803,00017.82%
Prosight Management, LP 2,515,072$6,011,0003.33%
22NW, LP 804,410$1,923,0002.54%
Broadfin Capital, LLC 2,578,003$6,161,0001.14%
NEA Management Company, LLC 4,141,308$9,898,0000.82%
Opaleye Management Inc. 490,000$1,171,0000.42%
PA Capital LLC 152,977$366,0000.36%
683 Capital Management, LLC 923,700$2,208,0000.25%
ESSEX INVESTMENT MANAGEMENT CO LLC 414,982$992,0000.14%
Hudson Bay Capital Management LP 1,475,000$3,525,0000.10%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders